Progress in secondary prevention of stroke with PROGRESS

Current Hypertension Reports

Volumn 4, Issue 1, 2002, Pages 39-40

  Schiffrin, Ernesto L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; PERINDOPRIL; RECURRENCE; TREATMENT OUTCOME;

EID: 0036484091     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0051-0     Document Type: Note

References (5)

1. Collins R, Peto F, MacMahon S: Blood pressure, stroke, and coronary heart disease, part 2: short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990, 335:827-838.
2. Staessen JA, Wang J: Blood-pressure lowering for the secondary prevention of stroke. Lancet 2001, 358:1026-1027.
3. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, rami-pril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145-154.
4. Hansson L, Lindholm LH, Niskanen L, et al, and the CAPPP Study Group: Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353:611-616.
5. Messerli FH, Grossman E, Goldbourt U: Are β-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 1998, 279:1903-1907.